nnmt snps pharmacogenetics 5 amino 1mq 5-Amino-1MQ Peptide 5-Amino-1MQ 10mg | NNMT Inhibitor

015 STAGE 1 Lv

AOD-9604 is sold for research purposes only and is not FDA-approved for human therapeutic use

Physician consultation before use remains paramount

Research Use Limitation Used solely for laboratory and in vitro research Not approved for human consumption Not approved for veterinary use Not intended for diagnostic purposes Not intended for therapeutic applications Not permitted for clinical administration For research use only Independently analysed by Liquilabs s.r.o

If you are making a subcutaneous injection just under your skin, pinch the area where you will be taking the shot

In naturally aged mouse models (1820 months old), daily oral administration of 5-amino-1mq capsules for 12 consecutive weeks significantly reduced NNMT activity and increased NAD+ levels in various tissues (liver, kidney, adipose tissue), along with markedly elevated expression of SIRT1 and SIRT3 proteins